Skip to main content

Advertisement

SpringerLink
Log in

A comprehensive review of tumor proliferative and suppressive role of semaphorins and therapeutic approaches

  • Review
  • Published:
Biophysical Reviews Aims and scope Submit manuscript

Abstract

Semaphorins have been traditionally known as axon guidance proteins that negatively regulate axonal growth. However, in the past couple of decades, their versatile role in so many other biological processes has come to prominence as well. One such example is their role in cancer. In this review article, the focus was on the tumor proliferative and tumor suppressive role of all 20 semaphorin family members under the 7 semaphorin classes found in vertebrates and invertebrates as well as the ongoing and emerging therapeutic approaches to combat semaphorin-mediated cancers. Except sema6C, 19 of the 20 non-viral semaphorin family members have been discovered to be associated with cancer in one way or another. Eleven semaphorin family members have been discovered to be tumor proliferative and 8 to be tumor suppressive. Six therapeutic avenues and their safety profiles have been discussed which are currently at use or at the various stages of development. Finally, perspectives on which approach is the best for treating cancers associated with semaphorins have been given.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Ahammad I, Sarker MRI, Khan AM, Islam S, Hossain M (2019) Virtual screening to identify novel inhibitors of Pan ERBB family of proteins from natural products with known anti-tumorigenic properties. Int J Pept Res Ther

  • Alto, L.T. and Terman, J.R. (2016). Semaphorins and their signaling mechanisms. Methods in Molecular Biology, [online] pp.1–25. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538787. Accessed 11 Jun 2020

  • Ayala GE, Dai H, Powell M, Li R, Ding Y, Wheeler TM, Shine D, Kadmon D, Thompson T, Miles BJ, Ittmann MM, Rowley D (2008) Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res 14(23):7593–7603

    CAS  PubMed  Google Scholar 

  • Bachelder, R.E., Lipscomb, E.A., Lin, X., Wendt, M.A., Chadborn, N.H., Eickholt, B.J. and Mercurio, A.M. (2003). Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Research, 63(17), pp.5230–5233. Available at: http://www.ncbi.nlm.nih.gov/pubmed/14500350. Accessed 11 Jun 2020

  • Badache A, Gonçalves A (2006) The ErbB2 signaling network as a target for breast cancer therapy. J Mammary Gland Biol Neoplasia 11(1):13–25

    PubMed  Google Scholar 

  • Bao Z-Z, Jin Z (2006) Sema3D andSema7A have distinct expression patterns in chick embryonic development. Dev Dyn 235(8):2282–2289

    CAS  PubMed  PubMed Central  Google Scholar 

  • Barr MP, Byrne AM, Duffy AM, Condron CM, Devocelle M, Harriott P, Bouchier-Hayes DJ, Harmey JH (2005) A peptide corresponding to the neuropilin-1-binding site on VEGF165 induces apoptosis of neuropilin-1-expressing breast tumour cells. Br J Cancer 92(2):328–333

    CAS  PubMed  PubMed Central  Google Scholar 

  • Barr, M.P., Bouchier-Hayes, D.J. and Harmey, J.J. (2008). Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia. International Journal of Oncology, 32(1), pp.41–48. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18097541 Accessed 11 Jun. 2020

  • Basile, J.R., Barac, A., Zhu, T., Guan, K.-L. and Gutkind, J.S. (2004). Class IV Semaphorins promote angiogenesis by stimulating rho-initiated pathways through Plexin-B. Cancer Research 64(15), pp.5212–5224. Available at: http://cancerres.aacrjournals.org/content/64/15/5212.short [Accessed 11 Jun. 2020]

  • Basile JR, Afkhami T, Gutkind JS (2005) Semaphorin 4D/Plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol Cell Biol 25(16):6889–6898

    CAS  PubMed  PubMed Central  Google Scholar 

  • Basile JR, Holmbeck K, Bugge TH, Gutkind JS (2007) MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem 282(9):6899–6905

    CAS  PubMed  Google Scholar 

  • Bellon A, Luchino J, Haigh K, Rougon G, Haigh J, Chauvet S, Mann F (2010) VEGFR2 (KDR/Flk1) signaling mediates axon growth in response to semaphorin 3E in the developing brain. Neuron 66(2):205–219

    CAS  PubMed  Google Scholar 

  • Burkhardt C, Müller M, Badde A, Garner CC, Gundelfinger ED, Püschel AW (2005) Semaphorin 4B interacts with the post-synaptic density protein PSD-95/SAP90 and is recruited to synapses through a C-terminal PDZ-binding motif. FEBS Lett 579(17):3821–3828

    CAS  PubMed  Google Scholar 

  • Butti R, Kumar TV, Nimma R, Kundu GC (2018) Impact of semaphorin expression on prognostic characteristics in breast cancer. Breast Cancer: Targets and Therapy 10:79–88

    CAS  Google Scholar 

  • Casazza A, Finisguerra V, Capparuccia L, Camperi A, Swiercz JM, Rizzolio S, Rolny C, Christensen C, Bertotti A, Sarotto I, Risio M, Trusolino L, Weitz J, Schneider M, Mazzone M, Comoglio PM, Tamagnone L (2010) Sema3E–Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. J Clin Investig 120(8):2684–2698

    CAS  PubMed  PubMed Central  Google Scholar 

  • Casazza A, Fu X, Johansson I, Capparuccia L, Andersson F, Giustacchini A, Squadrito ML, Venneri MA, Mazzone M, Larsson E, Carmeliet P, De Palma M, Naldini L, Tamagnone L, Rolny C (2011) Systemic and targeted delivery of semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models. Arterioscler Thromb Vasc Biol 31(4):741–749

    CAS  PubMed  Google Scholar 

  • Casazza A, Kigel B, Maione F, Capparuccia L, Kessler O, Giraudo E, Mazzone M, Neufeld G, Tamagnone L (2012) Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant semaphorin 3E isoform. EMBO Molecular Medicine 4(3):234–250

    CAS  PubMed  PubMed Central  Google Scholar 

  • Castellani V, Chédotal A, Schachner M, Faivre-Sarrailh C, Rougon G (2000) Analysis of the L1-deficient mouse phenotype reveals cross-talk between Sema3A and L1 signaling pathways in axonal guidance. Neuron 27(2):237–249

    CAS  PubMed  Google Scholar 

  • Castro-Rivera E, Ran S, Brekken RA, Minna JD (2008) Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells. Cancer Res 68(20):8295–8303

    CAS  PubMed  PubMed Central  Google Scholar 

  • Catalano A, Lazzarini R, Di Nuzzo S, Orciari S, Procopio A (2009) The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-κB to mediate survival and anchorage-independent growth of malignant mesothelioma cells. Cancer Res 69(4):1485–1493

    CAS  PubMed  Google Scholar 

  • Cebecauer M, Spitaler M, Serge A, Magee AI (2010) Signalling complexes and clusters: functional advantages and methodological hurdles. J Cell Sci 123(3):309–320

    CAS  PubMed  Google Scholar 

  • Chen H, Chédotal A, He Z, Goodman CS, Tessier-Lavigne M (1997) Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 19(3):547–559

    CAS  PubMed  Google Scholar 

  • Christensen, C.R., Klingelhöfer, J., Tarabykina, S., Hulgaard, E.F., Kramerov, D. and Lukanidin, E. (1998). Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Research, 58(6), pp.1238–1244. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9515811 Accessed 11 Jun. 2020

  • Conrotto P, Corso S, Gamberini S, Comoglio PM, Giordano S (2004) Interplay between scatter factor receptors and B plexins controls invasive growth. Oncogene 23(30):5131–5137

    CAS  PubMed  Google Scholar 

  • Conrotto P, Valdembri D, Corso S, Serini G, Tamagnone L, Comoglio PM, Bussolino F, Giordano S (2005) Sema4D induces angiogenesis through met recruitment by plexin B1. Blood 105(11):4321–4329

    CAS  PubMed  Google Scholar 

  • Correa RG, Sasahara RM, Bengtson MH, Katayama MLH, Salim ACM, Brentani MM, Sogayar MC, de Souza SJ, Simpson AJG (2001) Human Semaphorin 6B [(HSA)SEMA6B], A novel human class 6 semaphorin gene: alternative splicing and all-trans-retinoic acid-dependent downregulation in glioblastoma cell lines. Genomics 73(3):343–348

    CAS  PubMed  Google Scholar 

  • D’Apice L, Costa V, Valente C, Trovato M, Pagani A, Manera S, Regolo L, Zambelli A, Ciccodicola A, De Berardinis P (2013) Analysis of SEMA6B gene expression in breast cancer: identification of a new isoform. Biochim Biophys Acta Gen Subj 1830(10):4543–4553

    Google Scholar 

  • Delaire, S., Billard, C., Tordjman, R., Chédotal, A., Elhabazi, A., Bensussan, A. and Boumsell, L. (2001). Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. Journal of Immunology (Baltimore, Md.: 1950), [online] 166(7), pp.4348–4354. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11254688 Accessed 11 Jun. 2020

  • Delgoffe, G.M., Woo, S.-R., Turnis, M.E., Gravano, D.M., Guy, C., Overacre, A.E., Bettini, M.L., Vogel, P., Finkelstein, D., Bonnevier, J., Workman, C.J. and Vignali, D.A.A. (2013). Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis. Nature 501(7466), pp.252–256. Available at: https://www.nature.com/articles/nature12428?page=6 Accessed 22 Mar. 2020

  • Dhanabal, M., Wu, F., Alvarez, E., McQueeney, K.D., Jeffers, M., MacDougall, J., Boldog, F.L., Hackett, C., Shenoy, S., Khramtsov, N., Weiner, J., Lichenstein, H.S. and LaRochelle, W.J. (2005). Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis. Cancer Biology & Therapy, 4(6), pp.659–668. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15917651 Accessed 11 Jun. 2020

  • Ding Y, He D, Florentin D, Frolov A, Hilsenbeck S, Ittmann M, Kadmon D, Miles B, Rowley D, Ayala G (2013) Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer. Clin Cancer Res 19(22):6101–6111

    CAS  PubMed  PubMed Central  Google Scholar 

  • Drabkin, H., Nasarre, P. and Gemmill, R. (2014). The emerging role of class-3 semaphorins and their neuropilin receptors in oncology. OncoTargets and Therapy, p.1663. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181631/pdf/ott-7-1663.pdf Accessed 19 May 2020

  • Evans EE, Jonason AS, Bussler H, Torno S, Veeraraghavan J, Reilly C, Doherty MA, Seils J, Winter LA, Mallow C, Kirk R, Howell A, Giralico S, Scrivens M, Klimatcheva K, Fisher TL, Bowers WJ, Paris M, Smith ES, Zauderer M (2015) Antibody blockade of semaphorin 4D promotes immune infiltration into tumor and enhances response to other immunomodulatory therapies. Cancer Immunology Research 3(6):689–701

    CAS  PubMed  Google Scholar 

  • Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, Asplund A, Sjöstedt E, Lundberg E, Szigyarto CA-K, Skogs M, Takanen JO, Berling H, Tegel H, Mulder J, Nilsson P, Schwenk JM, Lindskog C, Danielsson F, Mardinoglu A, Sivertsson Å, von Feilitzen K, Forsberg M, Zwahlen M, Olsson I, Navani S, Huss M, Nielsen J, Ponten F, Uhlén M (2013) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 13(2):397–406

    PubMed  PubMed Central  Google Scholar 

  • Fazzari P, Penachioni J, Gianola S, Rossi F, Eickholt BJ, Maina F, Alexopoulou L, Sottile A, Comoglio P, Flavell RA, Tamagnone L (2007) Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis. BMC Developmental Biology 7(1):55

    PubMed  PubMed Central  Google Scholar 

  • Feiner L, Koppel AM, Kobayashi H, Raper JA (1997) Secreted chick semaphorins bind recombinant neuropilin with similar affinities but bind different subsets of neurons in situ. Neuron 19(3):539–545

    CAS  PubMed  Google Scholar 

  • Foley K, Rucki AA, Xiao Q, Zhou D, Leubner A, Mo G, Kleponis J, Wu AA, Sharma R, Jiang Q, Anders RA, Iacobuzio-Donahue CA, Hajjar KA, Maitra A, Jaffee EM, Zheng L (2015) Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer. Science Signaling 8(388):ra77–ra77

    PubMed  PubMed Central  Google Scholar 

  • Fukushima Y, Okada M, Kataoka H, Hirashima M, Yoshida Y, Mann F, Gomi F, Nishida K, Nishikawa S-I, Uemura A (2011) Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. J Clin Investig 121(5):1974–1985

    CAS  PubMed  PubMed Central  Google Scholar 

  • Garcia-Areas R, Libreros S, Amat S, Keating P, Carrio R, Robinson P, Blieden C, Iragavarapu-Charyulu V (2014) Semaphorin7A promotes tumor growth and exerts a pro-angiogenic effect in macrophages of mammary tumor-bearing mice. Front Physiol 5

  • Garcia-Areas R, Libreros S, Simoes M, Castro-Silva C, Gazaniga N, Amat S, Jaczewska J, Keating P, Schilling K, Brito M, Wojcikiewicz EP, Iragavarpu-Charyulu V (2017) Suppression of tumor-derived Semaphorin 7A and genetic ablation of host-derived Semaphorin 7A impairs tumor progression in a murine model of advanced breast carcinoma. Int J Oncol 51(5):1395–1404

    CAS  PubMed  PubMed Central  Google Scholar 

  • Geretti E, Shimizu A, Klagsbrun M (2008) Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 11(1):31–39

    CAS  PubMed  Google Scholar 

  • Gomez HL, Doval DC, Chavez MA, Ang PC-S, Aziz Z, Nag S, Ng C, Franco SX, Chow LWC, Arbushites MC, Casey MA, Berger MS, Stein SH, Sledge GW (2008) Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast Cancer. J Clin Oncol 26(18):2999–3005

    CAS  PubMed  Google Scholar 

  • Goshima, Y., Ito, T., Sasaki, Y. and Nakamura, F. (2002). Semaphorins as signals for cell repulsion and invasion. The Journal of Clinical Investigation 109(8), pp.993–998. Available at: https://www.jci.org/articles/view/15467 Accessed 11 Jun. 2020

  • Grandclement C, Borg C (2011) Neuropilins: a new target for cancer therapy. Cancers 3(2):1899–1928

    CAS  PubMed  PubMed Central  Google Scholar 

  • Gu C, Giraudo E (2013) The role of semaphorins and their receptors in vascular development and cancer. Exp Cell Res 319(9):1306–1316

    CAS  PubMed  PubMed Central  Google Scholar 

  • Gurrapu S, Pupo E, Franzolin G, Lanzetti L, Tamagnone L (2018) Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential. Cell Death & Differentiation 25(7):1259–1275

    CAS  Google Scholar 

  • Guttmann-Raviv N, Kessler O, Shraga-Heled N, Lange T, Herzog Y, Neufeld G (2006) The neuropilins and their role in tumorigenesis and tumor progression. Cancer Lett 231(1):1–11

    CAS  PubMed  Google Scholar 

  • Hao J, Yu J (2018) Semaphorin 3C and its receptors in cancer and cancer stem-like cells. Biomedicines 6(2):42

    PubMed Central  Google Scholar 

  • Herman, J.G. and Meadows, G.G. (2007). Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells. International Journal of Oncology, 30(5), pp.1231–1238. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17390026 Accessed 11 Jun. 2020

  • Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, Miki T, Nakamura Y, Katagiri T (2006) Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma. Int J Oncol

  • Hong T-M, Chen Y-L, Wu Y-Y, Yuan A, Chao Y-C, Chung Y-C, Wu M-H, Yang S-C, Pan S-H, Shih J-Y, Chan W-K, Yang P-C (2007) Targeting Neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer Res 13(16):4759–4768

    CAS  PubMed  Google Scholar 

  • Huang C, Wang Y, Huang J-H, Liu W (2017) Sema3A drastically suppresses tumor growth in oral cancer xenograft model of mice. BMC Pharmacol Toxicol 18(1)

  • Huber AB, Kolodkin AL, Ginty DD, Cloutier J-F (2003) Signaling at thegrowthcone: ligand-receptor complexes and the control of axon growth and guidance. Annu Rev Neurosci 26(1):509–563

    CAS  PubMed  Google Scholar 

  • Inoue N, Nishizumi H, Naritsuka H, Kiyonari H, Sakano H (2018) Sema7A/PlxnCl signaling triggers activity-dependent olfactory synapse formation. Nat Commun 9(1)

  • Jacob L, Sawma P, Garnier N, Meyer LAT, Fritz J, Hussenet T, Spenlé C, Goetz J, Vermot J, Fernandez A, Baumlin N, Aci-Sèche S, Orend G, Roussel G, Crémel G, Genest M, Hubert P, Bagnard D (2016) Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide. Oncotarget 7(36):57851–57865

    PubMed  PubMed Central  Google Scholar 

  • Janssen BJC, Robinson RA, Pérez-Brangulí F, Bell CH, Mitchell KJ, Siebold C, Jones EY (2010) Structural basis of semaphorin–plexin signalling. Nature 467(7319):1118–1122

    CAS  PubMed  PubMed Central  Google Scholar 

  • Jian H, Zhao Y, Liu B, Lu S (2014) SEMA4b inhibits MMP9 to prevent metastasis of non-small cell lung cancer. Tumor Biol 35(11):11051–11056

    CAS  Google Scholar 

  • Jian H, Zhao Y, Liu B, Lu S (2015) SEMA4B inhibits growth of non-small cell lung cancer in vitro and in vivo. Cell Signal 27(6):1208–1213

    CAS  PubMed  Google Scholar 

  • Jiang H, Chen C, Sun Q, Wu J, Qiu L, Gao C, Liu W, Yang J, Jun N, Dong J (2016) The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer. OncoTargets and Therapy 9:5737–5750

    CAS  PubMed  PubMed Central  Google Scholar 

  • Julien F, Bechara A, Fiore R, Nawabi H, Zhou H, Hoyo-Becerra C, Bozon M, Rougon G, Grumet M, Püschel AW, Sanes JR, Castellani V (2005) Dual functional activity of semaphorin 3B is required for positioning the anterior commissure. Neuron 48(1):63–75

    CAS  PubMed  Google Scholar 

  • Jurcak NR, Fujiwara K, Rucki AA, Foley K, Murphy A, Muth S, Brittingham A, Jaffee EM, Zheng L (2018) Abstract 3026: role of AnnexinA2, Sema3D and PlexinD1 in mediating perineural invasion as a mechanism of metastasis in pancreatic ductal adenocarcinoma. Tumor Biol

  • Kang S, Nakanishi Y, Kioi Y, Okuzaki D, Kimura T, Takamatsu H, Koyama S, Nojima S, Nishide M, Hayama Y, Kinehara Y, Kato Y, Nakatani T, Shimogori T, Takagi J, Toyofuku T, Kumanogoh A (2018) Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization. Nat Immunol 19(6):561–570

    CAS  PubMed  Google Scholar 

  • Kapil S, Sharma BK, Patil M, Elattar S, Yuan J, Hou SX, Kolhe R, Satyanarayana A (2017) The cell polarity protein Scrib functions as a tumor suppressor in liver cancer. Oncotarget 8(16)

  • Kigel B, Rabinowicz N, Varshavsky A, Kessler O, Neufeld G (2011) Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling. Blood 118(15):4285–4296

    CAS  PubMed  Google Scholar 

  • Kundu, A., Kho, E.-Y., Shelar, S.B., Nam, H., Brinkley, G., Darshan, S., Tang, Y., Kirkman, R., Crossman, D.K., Varambally, S., Rowe, G.C., Wei, S., Buckhaults, P. and Sudarshan, S. (2018). Abstract 4483: functional implications ofPRDM16loss in kidney cancer. Molecular and Cellular Biology / Genetics

  • Lee T-H, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK, Avraham S (2007) Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. PLoS Medicine 4(6):e186

    PubMed  PubMed Central  Google Scholar 

  • Lee J, Shin YJ, Lee K, Cho HJ, Sa JK, Lee S-Y, Kim S-H, Lee J, Yoon Y, Nam D-H (2018) Anti-SEMA3A antibody: a novel therapeutic agent to suppress glioblastoma tumor growth. Cancer Res Treat 50(3):1009–1022

    CAS  PubMed  Google Scholar 

  • Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141(7):1117–1134

    CAS  PubMed  PubMed Central  Google Scholar 

  • Li, J., Wang, H., Li, J., Bao, J. and Wu, C. (2016). Discovery of a potential HER2 inhibitor from natural products for the treatment of HER2-positive breast cancer. International Journal of Molecular Sciences, 17(7), p.1055. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964431/ Accessed 22 Jul. 2019

  • Li Z, Hao J, Duan X, Wu N, Zhou Z, Yang F, Li J, Zhao Z, Huang S (2017) The role of semaphorin 3A in bone remodeling. Front Cell Neurosci 11

  • Liang W-C, Dennis MS, Stawicki S, Chanthery Y, Pan Q, Chen Y, Eigenbrot C, Yin J, Koch AW, Wu X, Ferrara N, Bagri A, Tessier-Lavigne M, Watts RJ, Wu Y (2007) Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. J Mol Biol 366(3):815–829

    CAS  PubMed  Google Scholar 

  • Lim HS, Kim CS, Kim JS, Yu SK, Go DS, Lee, SA, Moon SM, Chun, HS, Kim, SG Kim, DK (2017) Suppression of oral carcinoma oncogenic activity by microRNA-203 via down-regulation of SEMA6A. Anticancer Res 37(10):5425–5433

  • Liu X-B (2005) Stereotyped axon pruning via plexin signaling is associated with synaptic complex elimination in the hippocampus. J Neurosci 25(40):9124–9134

  • Liu Y, Li R, Yin K, Ren G, Zhang Y (2017) The crucial role of SEMA3F in suppressing the progression of oral squamous cell carcinoma. Cellular & Molecular Biology Letters 22(1)

  • Lontos, K., Adamik, J., Tsagianni, A., Galson, D.L., Chirgwin, J.M. and Suvannasankha, A. (2018). The role of semaphorin 4D in bone remodeling and cancer metastasis. Frontiers in Endocrinology, 9. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018527/pdf/fendo-09-00322.pdf Accessed 28 Apr. 2020

  • Loria R, Bon G, Perotti V, Gallo E, Bersani I, Baldassari P, Porru M, Leonetti C, Di Carlo S, Visca P, Brizzi MF, Anichini A, Mortarini R, Falcioni R (2014) Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells. Oncotarget 6(5):2779–2793

    PubMed Central  Google Scholar 

  • Lu, T.-P., Tsai, M.-H., Lee, J.-M., Hsu, C.-P., Chen, P.-C., Lin, C.-W., Shih, J.-Y., Yang, P.-C., Hsiao, C.K., Lai, L.-C. and Chuang, E.Y. (2010). Identification of a novel biomarker, SEMA5A, for non–small cell lung carcinoma in nonsmoking women. Cancer Epidemiology and Prevention Biomarkers 19(10), pp.2590–2597. Available at: http://cebp.aacrjournals.org/content/19/10/2590.long Accessed 11 Jun. 2020

  • Lu, T.-P., Tsai, M.-H., Hsiao, C.K., Lai, L.-C. and Chuang, E.Y. (2012). Expression and functions of semaphorins in cancer. Translational Cancer Research 1(2), pp.74–87. Available at: http://tcr.amegroups.com/article/view/388/759 Accessed 11 Jun. 2020

  • Lu Y, Xu Q, Chen L, Zuo Y, Liu S, Hu Y, Li X, Li Y, Zhao X (2016) Expression of semaphorin 6D and its receptor plexin-A1 in gastric cancer and their association with tumor angiogenesis. Oncol Lett 12(5):3967–3974

    CAS  PubMed  PubMed Central  Google Scholar 

  • Maejima R, Tamai K, Shiroki T, Yokoyama M, Shibuya R, Nakamura M, Yamaguchi K, Abue M, Oikawa T, Noguchi T, Miura K, Fujiya T, Sato I, Iijima K, Shimosegawa T, Tanaka N, Satoh K (2016) Enhanced expression of semaphorin 3E is involved in the gastric cancer development. Int J Oncol 49(3):887–894

    CAS  PubMed  PubMed Central  Google Scholar 

  • Malik, M.F.A., Satherley, L.K., Davies, E.L., Ye, L. and Jiang, W.G. (2016). Expression of semaphorin 3C in breast cancer and its impact on adhesion and invasion of breast cancer cells. Anticancer Research, [online] 36(3), pp.1281–1286. Available at: http://www.ncbi.nlm.nih.gov/pubmed/26977026 Accessed 11 Jun. 2020

  • Man J, Shoemake J, Zhou W, Fang X, Wu Q, Rizzo A, Prayson R, Bao S, Rich JN, Yu JS (2014) Sema3C promotes the survival and tumorigenicity of glioma stem cells through Rac1 activation. Cell Rep 9(5):1812–1826

    CAS  PubMed  PubMed Central  Google Scholar 

  • Meyer LAT, Fritz J, Pierdant-Mancera M, Bagnard D (2016) Current drug design to target the semaphorin/neuropilin/plexin complexes. Cell Adhes Migr 10(6):700–708

    CAS  Google Scholar 

  • Mitsogiannis MD, Little GE, Mitchell KJ (2017) Semaphorin-plexin signaling influences early ventral telencephalic development and thalamocortical axon guidance. Neural Dev 12(1)

  • Miyato H, Tsuno NH, Kitayama J (2012) Semaphorin 3C is involved in the progression of gastric cancer. Cancer Sci 103(11):1961–1966

    CAS  PubMed  PubMed Central  Google Scholar 

  • Müller MW, Giese NA, Swiercz JM, Ceyhan GO, Esposito I, Hinz U, Büchler P, Giese T, Büchler MW, Offermanns S, Friess H (2007) Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Int J Cancer 121(11):2421–2433

    PubMed  Google Scholar 

  • Nakamura, F., Kalb, R. G. and Strittmatter, S. M. (2000) ‘Molecular basis of semaphorin-mediated axon guidance’, Journal of Neurobiology. John Wiley & Sons, Inc., 44(2), pp. 219–229

  • Narazaki M, Segarra M, Tosato G (2008) Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A. Blood 111(8):4126–4136

    CAS  PubMed  PubMed Central  Google Scholar 

  • Nasarre P, Kusy S, Constantin B, Castellani V, Drabkin HA, Bagnard D, Roche J (2005) Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion. Neoplasia 7(2):180–189

    CAS  PubMed  PubMed Central  Google Scholar 

  • Neufeld G, Kessler O (2008) The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer 8(8):632–645

    CAS  PubMed  Google Scholar 

  • Neufeld G, Sabag AD, Rabinovicz N, Kessler O (2011) Semaphorins in angiogenesis and tumor progression. Cold Spring Harbor Perspectives in Medicine 2(1):a006718–a006718

    Google Scholar 

  • Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir-Zvi I, Ziv K, Kessler O (2016) The role of the semaphorins in cancer. Cell Adhes Migr 10(6):652–674

    CAS  Google Scholar 

  • Orr BO, Fetter RD, Davis GW (2017) Retrograde semaphorin–plexin signalling drives homeostatic synaptic plasticity. Nature 550(7674):109–113

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase T, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S (2003) Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet 36(1):40–45

    PubMed  Google Scholar 

  • Paldy E, Simonetti M, Worzfeld T, Bali KK, Vicuña L, Offermanns S, Kuner R (2017) Semaphorin 4C Plexin-B2 signaling in peripheral sensory neurons is pronociceptive in a model of inflammatory pain. Nat Commun 8(1)

  • Pan Q, Chanthery Y, Liang W-C, Stawicki S, Mak J, Rathore N, Tong RK, Kowalski J, Yee SF, Pacheco G, Ross S, Cheng Z, Le Couter J, Plowman G, Peale F, Koch AW, Wu Y, Bagri A, Tessier-Lavigne M, Watts RJ (2007) Blocking Neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 11(1):53–67

    CAS  PubMed  Google Scholar 

  • Pan G-Q, Ren H-Z, Zhang S-F, Wang X-M, Wen J-F (2009) Expression of semaphorin 5A and its receptor plexin B3 contributes to invasion and metastasis of gastric carcinoma. World Journal of Gastroenterology 15(22):2800

    CAS  PubMed  PubMed Central  Google Scholar 

  • Pectasides E, Bass AJ (2015) ERBB2 emerges as a new target for colorectal cancer. Cancer Discovery 5(8):799–801

    CAS  PubMed  PubMed Central  Google Scholar 

  • Pellet-Many C, Frankel P, Jia H, Zachary I (2008) Neuropilins: structure, function and role in disease. Biochem J 411(2):211–226

    CAS  PubMed  Google Scholar 

  • Potiron V, Nasarre P, Roche J, Healy C, Boumsell L (n.d.) Semaphorin signaling in the immune system. Advances in Experimental Medicine and Biology:132–144

  • Rehman M, Tamagnone L (2013) Semaphorins in cancer: biological mechanisms and therapeutic approaches. Semin Cell Dev Biol 24(3):179–189

    CAS  PubMed  Google Scholar 

  • Rogalewski A, Dittgen T, Klugmann M, Kirsch F, Krüger C, Pitzer C, Minnerup J, Schäbitz W-R, Schneider A (2010) Semaphorin 6A improves functional recovery in conjunction with motor training after cerebral ischemia. PLoS ONE 5(5):e10737

    PubMed  PubMed Central  Google Scholar 

  • Sabag, A.D., Bode, J., Fink, D., Kigel, B., Kugler, W. and Neufeld, G. (2012). Semaphorin-3D and semaphorin-3E inhibit the development of tumors from glioblastoma cells implanted in the cortex of the brain. PLoS ONE, 7(8), p.e42912

  • Sadanandam A, Varney ML, Singh S, Ashour AE, Moniaux N, Deb S, Lele SM, Batra SK, Singh RK (2010) High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis. Int J Cancer 127(6):1373–1383

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sadanandam A, Sidhu SS, Wullschleger S, Singh S, Varney ML, Yang C-S, Ashour AE, Batra SK, Singh RK (2012) Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation. Br J Cancer 107(3):501–507

    CAS  PubMed  PubMed Central  Google Scholar 

  • Saito T, Kasamatsu A, Ogawara K, Miyamoto I, Saito K, Iyoda M, Suzuki T, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K (2015) Semaphorin7A promotion of tumoral growth and metastasis in human oral cancer by regulation of G1 cell cycle and matrix metalloproteases: possible contribution to tumoral angiogenesis. PLOS ONE 10(9):e0137923

    PubMed  PubMed Central  Google Scholar 

  • Sakurai A, Gavard J, Annas-Linhares Y, Basile JR, Amornphimoltham P, Palmby TR, Yagi H, Zhang F, Randazzo PA, Li X, Weigert R, Gutkind JS (2010) Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras. Mol Cell Biol 30(12):3086–3098

    CAS  PubMed  PubMed Central  Google Scholar 

  • Schroeder R, Stevens C, Sridhar J (2014) Small molecule tyrosine kinase inhibitors of ErbB2/HER2/Neu in the treatment of aggressive breast cancer. Molecules 19(9):15196–15212

    PubMed  PubMed Central  Google Scholar 

  • Segarra M, Ohnuki H, Maric D, Salvucci O, Hou X, Kumar A, Li X, Tosato G (2012) Semaphorin 6A regulates angiogenesis by modulating VEGF signaling. Blood 120(19):4104–4115

    CAS  PubMed  PubMed Central  Google Scholar 

  • Shen C-Y, Chang Y-C, Chen L-H, Lin W-C, Lee Y-H, Yeh S-T, Chen H-K, Fang W, Hsu C-P, Lee J-M, Lu T-P, Hsiao P-W, Lai L-C, Tsai M-H, Chuang EY (2018) The extracellular SEMA domain attenuates intracellular apoptotic signaling of semaphorin 6A in lung cancer cells. Oncogenesis 7(12)

  • Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY (2006) Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Life Sci 79(25):2370–2381

    CAS  PubMed  Google Scholar 

  • Staton C, Kumar I, Reed M, Brown N (2007) Neuropilins in physiological and pathological angiogenesis. J Pathol 212(3):237–248

    CAS  PubMed  Google Scholar 

  • Sun T, Yang L, Kaur H, Pestel J, Looso M, Nolte H, Krasel C, Heil D, Krishnan RK, Santoni M-J, Borg J-P, Bünemann M, Offermanns S, Swiercz JM, Worzfeld T (2016) A reverse signaling pathway downstream of Sema4A controls cell migration via Scrib. J Cell Biol 216(1):199–215

    PubMed  Google Scholar 

  • Swiercz JM, Kuner R, Offermanns S (2004) Plexin-B1/RhoGEF–mediated RhoA activation involves the receptor tyrosine kinase ErbB-2. J Cell Biol 165(6):869–880

    CAS  PubMed  PubMed Central  Google Scholar 

  • Takahashi T, Fournier A, Nakamura F, Wang L-H, Murakami Y, Kalb RG, Fujisawa H, Strittmatter SM (1999) Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 99(1):59–69

    CAS  PubMed  Google Scholar 

  • Takamatsu H, Kumanogoh A (2012) Diverse roles for semaphorin−plexin signaling in the immune system. Trends Immunol 33(3):127–135

    CAS  PubMed  Google Scholar 

  • Takamatsu H, Okuno T, Kumanogoh A (2010) Regulation of immune cell responses by semaphorins and their receptors. Cellular & Molecular Immunology 7(2):83–88

    Google Scholar 

  • Tamagnone L (2012) Emerging role of semaphorins as major regulatory signals and potential therapeutic targets in cancer. Cancer Cell 22(2):145–152

    CAS  PubMed  Google Scholar 

  • Tamagnone L, Comoglio PM (2004) To move or not to move? EMBO Rep 5(4):356–361

    CAS  PubMed  PubMed Central  Google Scholar 

  • Tamagnone L, Artigiani S, Chen H, He Z, Ming G, Song H, Chedotal A, Winberg ML, Goodman CS, Poo M, Tessier-Lavigne M, Comoglio PM (1999) Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99(1):71–80

    CAS  PubMed  Google Scholar 

  • Taniguchi M, Masuda T, Fukaya M, Kataoka H, Mishina M, Yaginuma H, Watanabe M, Shimizu T (2005) Identification and characterization of a novel member of murine semaphorin family. Genes Cells 10(8):785–792

    CAS  PubMed  Google Scholar 

  • Tomizawa Y, Sekido Y, Kondo M, Gao B, Yokota J, Roche J, Drabkin H, Lerman MI, Gazdar AF, Minna JD (2001) Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci 98(24):13954–13959

    CAS  PubMed  PubMed Central  Google Scholar 

  • Toyofuku T (2004) Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev 18(4):435–447

    CAS  PubMed  PubMed Central  Google Scholar 

  • Tran TS, Kolodkin AL, Bharadwaj R (2007) Semaphorin regulation of cellular morphology. Annu Rev Cell Dev Biol 23(1):263–292

    CAS  PubMed  Google Scholar 

  • Valabrega G, Montemurro F, Aglietta M (2007) Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer. Ann Oncol 18(6):977–984

    CAS  PubMed  Google Scholar 

  • Valente, G., Nicotra, G., Arrondini, M., Castino, R., Capparuccia, L., Prat, M., Kerim, S., Tamagnone, L. and Isidoro, C. (2009). Co-expression of plexin-B1 and met in human breast and ovary tumours enhances the risk of progression. Cellular Oncol 31(6), pp.423–436. Available at: https://pubmed.ncbi.nlm.nih.gov/19940359/ Accessed 11 Jun. 2020

  • Vander-Kooi CW, Jusino MA, Perman B, Neau DB, Bellamy HD, Leahy DJ (2007) Structural basis for ligand and heparin binding to neuropilin B domains. Proc Natl Acad Sci 104(15):6152–6157

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wallerius, M., Wallmann, T., Bartish, M., O stling, J., Mezheyeuski, A., Tobin, N.P., Nygren, E., Pangigadde, P., Pellegrini, P., Squadrito, M.L., Ponten, F., Hartman, J., Bergh, J., De Milito, A., De Palma, M., Ostman, A., Andersson, J. and Rolny, C. (2016). Guidance molecule SEMA3A restricts tumor growth by differentially regulating the proliferation of tumor-associated macrophages. Cancer Res 76(11), pp.3166–3178. Available at: https://cancerres.aacrjournals.org/content/76/11/3166.article-info Accessed 5 Feb. 2020

  • Wang, X., Zbou, C., Qiu, G., Fan, J., Tang, H. and Peng, Z. (2008). Screening of new tumor suppressor genes in sporadic colorectal cancer patients. Hepato-Gastroenterology, 55(88), pp.2039–2044. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19260473 Accessed 11 Jun. 2020

  • Williamson M, de Winter P, Masters JR (2015) Plexin-B1 signalling promotes androgen receptor translocation to the nucleus. Oncogene 35(8):1066–1072

    PubMed  Google Scholar 

  • Worzfeld, T. and Offermanns, S. (2014). Semaphorins and plexins as therapeutic targets. Nature Reviews Drug Discovery 13(8), pp.603–621. Available at: https://www.nature.com/articles/nrd4337#ref-CR61 Accessed 3 Feb. 2020

  • Worzfeld T, Swiercz JM, Looso M, Straub BK, Sivaraj KK, Offermanns S (2012) ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis. J Clin Investig 122(4):1296–1305

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wronski MA, Raju N, Pillai R, Bogdan NJ, Marinelli ER, Nanjappan P, Ramalingam K, Arunachalam T, Eaton S, Linder KE, Yan F, Pochon S, Tweedle MF, Nunn AD (2005) Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor. J Biol Chem 281(9):5702–5710

    Google Scholar 

  • Wu, F., Zhou, Q., Yang, J., Duan, G., Ou, J., Zhang, R., Pan, F., Peng, Q., Tan, H., Ping, Y., Cui, Y., Qian, C., Yan, X. and Bian, X. (2011). Endogenous axon guiding chemorepulsant semaphorin-3F inhibits the growth and metastasis of colorectal carcinoma. Clinical Cancer Research 17(9), pp.2702–2711. Available at: http://clincancerres.aacrjournals.org/content/17/9/2702.long Accessed 11 Jun. 2020

  • Xiao J-B, Li X-L, Liu L, Wang G, Hao S-N, Dong H-J, Wang X-M, Zhang Y-F, Liu H-D (2018) The association of semaphorin 5A with lymph node metastasis and adverse prognosis in cervical cancer. Cancer Cell Int 18(1)

  • Yang S-C, Chang S-S, Chen CY-C (2011) Identifying HER2 inhibitors from natural products database. PLoS ONE 6(12):e28793

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yazdani U, Terman JR (2006) The semaphorins. Genome Biology 7(3):211 Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557745/

    PubMed  PubMed Central  Google Scholar 

  • Yong L-K, Lai S, Liang Z, Poteet E, Chen F, van Buren G, Fisher W, Mo Q, Chen C, Yao Q (2016) Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival. Oncotarget 7(52):87431–87448

    PubMed  PubMed Central  Google Scholar 

  • Yu R (2012) Effects of SEMA3G on migration and invasion of glioma cells. Oncol Rep

  • Zhao X-Y (2006) Expression of semaphorin 6D in gastric carcinoma and its significance. World Journal of Gastroenterology 12(45):7388

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhu X, Zhang X, Ye Z, Chen Y, Lv L, Zhang X, Hu H (2017) Silencing of semaphorin 3C suppresses cell proliferation and migration in MCF-7 breast cancer cells. Oncology Letters

Download references

Availability of data and material

Not applicable.

Code availability

Not applicable.

Author information

Authors and Affiliations

  1. Department of Biochemistry and Microbiology, North South University, Dhaka, 1229, Bangladesh

    Ishtiaque Ahammad

Authors
  1. Ishtiaque Ahammad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ishtiaque Ahammad.

Ethics declarations

Conflict of interest

The author declare that they have no conflict of interest.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahammad, I. A comprehensive review of tumor proliferative and suppressive role of semaphorins and therapeutic approaches. Biophys Rev 12, 1233–1247 (2020). https://doi.org/10.1007/s12551-020-00709-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12551-020-00709-1

Keywords

Search

Navigation